165 related articles for article (PubMed ID: 8691040)
1. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
[TBL] [Abstract][Full Text] [Related]
2. Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1505-9. PubMed ID: 9467073
[TBL] [Abstract][Full Text] [Related]
3. Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold.
Little MP; Muirhead CR
Int J Radiat Biol; 1998 Oct; 74(4):471-80. PubMed ID: 9798958
[TBL] [Abstract][Full Text] [Related]
4. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the degree of curvature in the cancer incidence dose-response in Japanese atomic bomb survivors with that in chromosome aberrations measured in vitro.
Little MP
Int J Radiat Biol; 2000 Oct; 76(10):1365-75. PubMed ID: 11057745
[TBL] [Abstract][Full Text] [Related]
6. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
7. Corrections in the atomic bomb data to examine low dose risk.
Baker GS; Hoel DG
Health Phys; 2003 Dec; 85(6):709-20. PubMed ID: 14626322
[TBL] [Abstract][Full Text] [Related]
8. Threshold and other departures from linear-quadratic curvature in the non-cancer mortality dose-response curve in the Japanese atomic bomb survivors.
Little MP
Radiat Environ Biophys; 2004 Jul; 43(2):67-75. PubMed ID: 15221316
[TBL] [Abstract][Full Text] [Related]
9. Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.
Little MP; Deltour I; Richardson S
Radiat Environ Biophys; 2000 Dec; 39(4):241-52. PubMed ID: 11200968
[TBL] [Abstract][Full Text] [Related]
10. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
11. Threshold models in radiation carcinogenesis.
Hoel DG; Li P
Health Phys; 1998 Sep; 75(3):241-50. PubMed ID: 9721832
[TBL] [Abstract][Full Text] [Related]
12. Radiation-related cancer risks at low doses among atomic bomb survivors.
Pierce DA; Preston DL
Radiat Res; 2000 Aug; 154(2):178-86. PubMed ID: 10931690
[TBL] [Abstract][Full Text] [Related]
13. The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors.
Little MP; Charles MW
Int J Radiat Biol; 1997 May; 71(5):589-602. PubMed ID: 9191904
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
Schneider U; Walsh L
Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
[TBL] [Abstract][Full Text] [Related]
15. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
Little MP; Hoel DG; Molitor J; Boice JD; Wakeford R; Muirhead CR
Radiat Res; 2008 Jun; 169(6):660-76. PubMed ID: 18494541
[TBL] [Abstract][Full Text] [Related]
16. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
18. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
19. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
20. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
Little MP; Hawkins MM; Charles MW; Hildreth NG
Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
